Products

CarciVac®

Onco BCG - Bacilo Calmette- Guérin

Indications

  • Carcinoma in situ (CIS) of urothelial squamous cells of the bladder
  • As adjuvant treatment following transurethral resection of primary or recurrent superficial papillary urothelial cell carcinoma (Ta, T1 stage)

Presentations

  • 3 vials x 40 mg/vial